← Open Payments lookup

YESIDE OJO: Open Payments

NPI 1760934913 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$835 in 35 payments from 11 companies in 2025. Trend: 2023 $604 · 2024 $382 · 2025 $835

Food & beverage: $835
CompanyPaymentsAmount
ABBVIE INC.16$285
Otsuka America Pharmaceutical, Inc.4$185
Vanda Pharmaceuticals Inc.3$75
Lundbeck LLC3$69
Tris Pharma Inc2$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Takeda Pharmaceuticals U.S.A., Inc.1$29
Alkermes, Inc.1$28
Teva Pharmaceuticals USA, Inc.1$25
TMS NeuroHealth Centers Inc.1$23

Products named: VRAYLAR, ABILIFY MAINTENA, REXULTI, HETLIOZ, Dyanavel XR, CAPLYTA, TRINTELLIX, ARISTADA.

Industry payments across MD — which companies pay providers there.